Main Profile
Manufacturer &
Marketer
Description in a few words:
Recordati, an Italian multinational pharmaceutical company, offers a wide range of innovative medicines, mainly for cardiovascular and urological disorders and unique treatments for rare diseases.
Founder:
Giovanni Recordati
Current Leadership:
Andrea Recordati, Group CEO
Miguel Isla, Executive VP International Specialty and Primary Care Business Unit
İsmail Yormaz, VP and Regional Director South East & General Manager Turkey
Founding Year:
1926
“One of Recordati’s strongest areas of operation is in orphan drug acquisition initiatives; while specialty and primary care divisions together with the OTC business are important segments, Recordati remains mostly intertwined with orphan drugs in the treatment of rare diseases, for which we boast a presence on all continents.”
Manufacturing
Total production Area m 2 (Sterile, solid) Total Lab Area m2
- Solid production + packaging > 3.329 m2
- Liquid and semi-solid production + packaging > 1.413 m2
- Dispensing and others > 845 m2
- Total production + packaging > 5.587 m2
- QC Laboratories (including Micro) > 830 m2
Number of machinery in Production and capacities: solid, liquid, sterile
- Main equipment in solids production + packaging > 59
- Solids production + packaging capacity > 39.850.000
- Main equipment in liquids and semi-solids production + packaging > 48
- Liquids and semi-solids production + packaging capacity > 39.550.000
Main product categories or therapies of focus
Main Product Categories: cardiology, urology, rare diseases
Product Forms: Granules, effervescent granules, tablets, film coated tablets, sugar coated tablets, capsules, drops, suspensions, solutions, creams, gels, ointments
Primary packaging production
Blisters, sachets, tubes, bottles
Serialization Service
Full serialization with 2D barcode printing and aggregation
Total number of delivered boxes/year
61 million (2019 planned)
R&D
R&D focus
Recordati is committed to the research and development of treatments for rare diseases and of new specialties within the area of urology.
Exports
Export % in revenues:
0.5% of net revenue
List of export countries:
Azerbaijan, Georgia, Somalia, Libya, Afghanistan, Albania, Turkish Republic of Northern Cyprus
In More Depth
Number of employees
703 (sales force 404, industrial 227, other departments 72)
GMP certificates (Çerkezköy Facility)
Turkish MoH
EU
Azerbaijan MoH
Kenyan MoH
Libyan MoH
Revenue or Growth Rate in past financial year
Annual net revenue growth 20.5% in 2018 (Turkey)
Contact:
Website: